49 results
8-K
EX-10.1
NGM
Ngm Biopharmaceuticals Inc
26 Feb 24
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
5:01pm
Obligations or any right of offset with respect thereto, and any failure by the Guaranteed Party to pursue (or elect among) such other rights … or remedies or to collect any payments from Parent or Merger Sub, or any such other Person or to realize upon or to exercise any such right of offset, and any
DEFA14A
NGM
Ngm Biopharmaceuticals Inc
28 Apr 21
Additional proxy soliciting materials
4:38pm
paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify
SC TO-T
NGM
Ngm Biopharmaceuticals Inc
8 Mar 24
Third party tender offer statement
4:53pm
fee was calculated by multiplying the transaction value by 0.0001476.
Table 2 – Fee Offset Claims and Sources
Inapplicable.
8-K
EX-99.1
NGM
Ngm Biopharmaceuticals Inc
17 Mar 20
NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
4:18pm
license fee received from Merck in the fourth quarter of 2018, partially offset by year-over-year increases in reimbursable research and development … offset by cash used in operations during the period.
About NGM Biopharmaceuticals, Inc.
NGM is a biopharmaceutical company focused on developing novel
DEFA14A
NGM
Ngm Biopharmaceuticals Inc
8 Apr 20
Additional proxy soliciting materials
8:05am
:
Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2
DEFA14A
vnmwzh
8 May 20
Additional proxy soliciting materials
4:31pm
8-K
EX-99.1
4vrqj 6joj
4 Aug 22
NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
qacy 6i12f
12 Aug 19
NGM Bio Provides Pipeline Update and Reports Second Quarter 2019 Financial Results
4:12pm
8-K
EX-99.1
nkyyrnyt8x upfckilx4
5 May 22
NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
dbnrs
12 Nov 19
NGM Reports Business Highlights and Third Quarter 2019 Financial Results
4:10pm
8-K
EX-99.1
34qhn wdwpw
3 Nov 22
NGM Bio Provides Business Highlights and Reports Third Quarter 2022 Financial Results
4:12pm
8-K
EX-99.1
bw7rv22c0 fa88w4
4 Mar 21
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2020 Financial Results
4:14pm
8-K
EX-99.1
kl6klkgr 3bbp
1 Mar 22
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results
4:11pm